Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on October 31, 2002; DOI 10.1182/blood-2002-05-1461.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1461v1
101/7/2620    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Numasaki, M.
Right arrow Articles by Lotze, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Numasaki, M.
Right arrow Articles by Lotze, M. T.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Right arrow Immunobiology
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 April 2003, Vol. 101, No. 7, pp. 2620-2627

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Interleukin-17 promotes angiogenesis and tumor growth

Muneo Numasaki, Jun-ichi Fukushi, Mayumi Ono, Satwant K. Narula, Paul J. Zavodny, Toshio Kudo, Paul D. Robbins, Hideaki Tahara, and Michael T. Lotze

From the Departments of Surgery and Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA; Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Sendai, Japan; Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Immunology, Schering-Plough Research Institute, Kenilworth, NJ; Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Interleukin-17 (IL-17) is a CD4 T-cell-derived proinflammatory cytokine. We investigated the effects of locally produced IL-17 by tumors as a means to evaluate its biologic function. Although recombinant IL-17 protein or retroviral transduction of IL-17 gene into tumors did not affect in vitro proliferation, IL-17 transfectants grew more rapidly in vivo when compared with controls. Immunostaining for Factor VIII revealed that tumors transduced with IL-17 had significantly higher vascular density when compared with controls. IL-17 indeed elicited neovascularization in rat cornea. In addition, angiogenic activity present in the conditioned media of CD4 T cells was markedly suppressed by neutralizing monoclonal antibody to IL-17. IL-17 had no direct effect on the growth of vascular endothelial cells, whereas IL-17 significantly stimulated migration. IL-17 also markedly promoted the cord formation of vascular endothelial cells. In addition, IL-17 up-regulated elaboration of a variety of proangiogenic factors by fibroblasts as well as tumor cells. These findings reveal a novel role for IL-17 as a CD4 T-cell-derived mediator of angiogenesis that stimulates vascular endothelial cell migration and cord formation and regulates production of a variety of proangiogenic factors. Furthermore, they suggest that inhibition of biologic action of IL-17 may have therapeutic benefits when applied to angiogenesis-related disorders.

© 2003 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
P. Muranski, A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, et al.
Tumor-specific Th17-polarized cells eradicate large established melanoma
Blood, July 15, 2008; 112(2): 362 - 373.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C. Loddenkemper, D. Nagorsen, and M. Zeitz
Foxp3 and microsatellite stability phenotype in colorectal cancer
Gut, June 1, 2008; 57(6): 725 - 726.
[Full Text] [PDF]


Home page
GutHome page
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Gut, June 1, 2008; 57(6): 772 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Shime, M. Yabu, T. Akazawa, K. Kodama, M. Matsumoto, T. Seya, and N. Inoue
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
J. Immunol., June 1, 2008; 180(11): 7175 - 7183.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Badoual, G. Bouchaud, N. E. H. Agueznay, E. Mortier, S. Hans, A. Gey, F. Fernani, S. Peyrard, P. L. -Puig, P. Bruneval, et al.
The Soluble {alpha} Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer
Cancer Res., May 15, 2008; 68(10): 3907 - 3914.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-S. Nam, M. Terabe, M.-J. Kang, H. Chae, N. Voong, Y.-a. Yang, A. Laurence, A. Michalowska, M. Mamura, S. Lonning, et al.
Transforming Growth Factor {beta} Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17
Cancer Res., May 15, 2008; 68(10): 3915 - 3923.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Yusuf, T. H. Nasti, S. K. Katiyar, M. K. Jacobs, M. D. Seibert, A. C. Ginsburg, L. Timares, H. Xu, and C. A. Elmets
Antagonistic Roles of CD4+ and CD8+ T-Cells in 7,12-Dimethylbenz(a)anthracene Cutaneous Carcinogenesis
Cancer Res., May 15, 2008; 68(10): 3924 - 3930.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Hirata, Y. Osuga, K. Hamasaki, O. Yoshino, M. Ito, A. Hasegawa, Y. Takemura, Y. Hirota, E. Nose, C. Morimoto, et al.
Interleukin (IL)-17A Stimulates IL-8 Secretion, Cyclooxygensase-2 Expression, and Cell Proliferation of Endometriotic Stromal Cells
Endocrinology, March 1, 2008; 149(3): 1260 - 1267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Yusuf, T. H. Nasti, J. A. Long, M. Naseemuddin, A. P. Lucas, H. Xu, and C. A. Elmets
Protective Role of Toll-like Receptor 4 during the Initiation Stage of Cutaneous Chemical Carcinogenesis
Cancer Res., January 15, 2008; 68(2): 615 - 622.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Liang, A. J. Long, F. Bennett, M. J. Whitters, R. Karim, M. Collins, S. J. Goldman, K. Dunussi-Joannopoulos, C. M. M. Williams, J. F. Wright, et al.
An IL-17F/A Heterodimer Protein Is Produced by Mouse Th17 Cells and Induces Airway Neutrophil Recruitment
J. Immunol., December 1, 2007; 179(11): 7791 - 7799.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S.-J. Liu, J.-P. Tsai, C.-R. Shen, Y.-P. Sher, C.-L. Hsieh, Y.-C. Yeh, A.-H. Chou, S.-R. Chang, K.-N. Hsiao, F.-W. Yu, et al.
Induction of a distinct CD8 Tnc17 subset by transforming growth factor-{beta} and interleukin-6
J. Leukoc. Biol., August 1, 2007; 82(2): 354 - 360.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Jinushi and G. Dranoff
Triggering Tumor Immunity through Angiogenesis Targeting
Clin. Cancer Res., July 1, 2007; 13(13): 3762 - 3764.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Danese, E. Dejana, and C. Fiocchi
Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation
J. Immunol., May 15, 2007; 178(10): 6017 - 6022.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Numasaki, M. Tagawa, F. Iwata, T. Suzuki, A. Nakamura, M. Okada, Y. Iwakura, S. Aiba, and M. Yamaya
IL-28 Elicits Antitumor Responses against Murine Fibrosarcoma
J. Immunol., April 15, 2007; 178(8): 5086 - 5098.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoshimura, A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, T. Ishibashi, A. Yoshimura, and H. Yoshida
Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism
J. Immunol., October 15, 2006; 177(8): 5377 - 5385.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Lamagna, M. Aurrand-Lions, and B. A. Imhof
Dual role of macrophages in tumor growth and angiogenesis
J. Leukoc. Biol., October 1, 2006; 80(4): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. You, X.-B. Shi, G. DuRaine, D. Haudenschild, C. G. Tepper, S. Hao Lo, R. Gandour-Edwards, R. W. de Vere White, and A. H. Reddi
Interleukin-17 Receptor-Like Gene Is a Novel Antiapoptotic Gene Highly Expressed in Androgen-Independent Prostate Cancer
Cancer Res., January 1, 2006; 66(1): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Numasaki, M. Watanabe, T. Suzuki, H. Takahashi, A. Nakamura, F. McAllister, T. Hishinuma, J. Goto, M. T. Lotze, J. K. Kolls, et al.
IL-17 Enhances the Net Angiogenic Activity and In Vivo Growth of Human Non-Small Cell Lung Cancer in SCID Mice through Promoting CXCR-2-Dependent Angiogenesis
J. Immunol., November 1, 2005; 175(9): 6177 - 6189.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C Tsutsumi-Miyahara, K-H Sonoda, K Egashira, M Ishibashi, H Qiao, T Oshima, T Murata, M Miyazaki, I F Charo, S Hamano, et al.
The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation
Br. J. Ophthalmol., September 1, 2004; 88(9): 1217 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Umemura, T. Kawabe, K. Shudo, H. Kidoya, M. Fukui, M. Asano, Y. Iwakura, G. Matsuzaki, R. Imamura, and T. Suda
Involvement of IL-17 in Fas ligand-induced inflammation
Int. Immunol., August 1, 2004; 16(8): 1099 - 1108.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. D. Dodon, Z. Li, S. Hamaia, and L. Gazzolo
Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells
J. Gen. Virol., July 1, 2004; 85(7): 1921 - 1932.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. ZCHARIA, S. METZGER, T. CHAJEK-SHAUL, H. AINGORN, M. ELKIN, Y. FRIEDMANN, T. WEINSTEIN, J.-P. LI, U. LINDAHL, and I. VLODAVSKY
Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior
FASEB J, February 1, 2004; 18(2): 252 - 263.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020